Showing 1 - 20 results of 83 for search '(complement OR (implement OR implementing)) c1q', query time: 0.34s Refine Results
  1. 1
  2. 2

    Prognostic implications of complement C1q-like 4 expression in breast cancer by Qing Zhang, Zhijun Xing, Lu Bai, Xiao Li, Fan Xu

    Published 2025-07-01
    “…Abstract Higher expression of Complement C1q-like protein 4 (C1ql4) in breast cancer may be associated with increased tumor malignancy. …”
    Get full text
    Article
  3. 3
  4. 4
  5. 5
  6. 6

    Complement C1q is associated with neuroinflammation and mediates the association between amyloid-β and tau pathology in Alzheimer’s disease by Fan Guo, Ze-Hu Sheng, Yan Fu, Zhi-Bo Wang, Rong-Ji Xue, Lan Tan, Meng-Shan Tan, Zuo-Teng Wang

    Published 2025-07-01
    “…Abstract Complement C1q initiates the classical complement pathway and becomes activated in Alzheimer’s disease (AD), contributing to the association between amyloid-β (Aβ) and tau pathologies. …”
    Get full text
    Article
  7. 7
  8. 8

    Hereditary C1q deficiency: a new family with C1qA deficiency by Cağman Sun-Tan, Tuba Turul Ozgür, Gamze Kilinç, Rezan Topaloğlu, Ozay Gököz, Sibel Ersoy-Evans, Ozden Sanal

    Published 2010-04-01
    “… Hereditary deficiency of complement component C1q is a rare genetic disorder with susceptibility to recurrent infections with polysaccharide-containing encapsulated microorganisms and a high prevalence of autoimmune diseases, most often systemic lupus erythematosus (SLE). …”
    Get full text
    Article
  9. 9
  10. 10

    Obesity enhances ovarian cancer chemotherapy efficacy through C1q-mediated tumor targeting and immune activation by Shiyi Xu, Nana Bie, Xinzhuang Su, Xiaojuan Zhang, Shiyu Li, Haojie Liu, Tuying Yong, Qing Chen, Xiangliang Yang, Lu Gan

    Published 2025-08-01
    “…Mechanistically, the protein corona, particularly enriched with complement component 1q (C1q) in the plasma of obese mice, significantly enhances the internalization of PLD by ovarian cancer cells and elicits strong immunogenic cell death (ICD) effects. …”
    Get full text
    Article
  11. 11
  12. 12

    Prediction of activity of low-molecular inhibitors of the classic complement pathway using computational screening approach by D. M. Karlinsky, A. P. Kaplun, M. E. Popov

    Published 2009-06-01
    “…Using the molecular docking we estimated the free energy of binding of low-molecular ligands with the first component of complement protein C1q. The theoretically predicted values of IC50 allow selecting ligands with the highest inhibitory potential for further in vitro experiments…”
    Get full text
    Article
  13. 13
  14. 14

    Elevated Plasma Complement C1Q Measured Subacutely after Traumatic Brain Injury Is Associated with Poor Functional Outcome Independent of Initial Injury Severity by Tracy Butler, Kewei Chen, Abigail Patchell, Xiangling Mao, Dikoma Shungu, Diany Paola Calderon, Jeanne T. Paz, Sudhin A. Shah

    Published 2025-01-01
    “…This study investigates the role of complement factor 1q (C1Q) in TBI recovery. Motivated by our rodent studies showing that thalamic inflammation post-TBI is dependent on C1Q and that blocking C1Q during the subacute period can prevent thalamic inflammation and improve aspects of TBI outcome, particularly sleep, we measured plasma C1Q levels 3–6 months post-injury in 27 patients with TBI ranging from complicated mild to severe, as well as 30 controls. …”
    Get full text
    Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20